Choosing the best trastuzumab- based adjuvant chemotherapy regimen

Should we abandon anthracyclines?

Harold J. Burstein, Martine J. Piccart-Gebhart, Edith A. Perez, Gabriel N. Hortobagyi, Norman Wolmark, Kathy S. Albain, Larry Norton, Eric P. Winer, Clifford A. Hudis

Research output: Contribution to journalArticle

33 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)2179-2182
Number of pages4
JournalJournal of Clinical Oncology
Volume30
Issue number18
DOIs
StatePublished - Jun 20 2012

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Burstein, H. J., Piccart-Gebhart, M. J., Perez, E. A., Hortobagyi, G. N., Wolmark, N., Albain, K. S., ... Hudis, C. A. (2012). Choosing the best trastuzumab- based adjuvant chemotherapy regimen: Should we abandon anthracyclines? Journal of Clinical Oncology, 30(18), 2179-2182. https://doi.org/10.1200/JCO.2012.42.0695

Choosing the best trastuzumab- based adjuvant chemotherapy regimen : Should we abandon anthracyclines? / Burstein, Harold J.; Piccart-Gebhart, Martine J.; Perez, Edith A.; Hortobagyi, Gabriel N.; Wolmark, Norman; Albain, Kathy S.; Norton, Larry; Winer, Eric P.; Hudis, Clifford A.

In: Journal of Clinical Oncology, Vol. 30, No. 18, 20.06.2012, p. 2179-2182.

Research output: Contribution to journalArticle

Burstein, HJ, Piccart-Gebhart, MJ, Perez, EA, Hortobagyi, GN, Wolmark, N, Albain, KS, Norton, L, Winer, EP & Hudis, CA 2012, 'Choosing the best trastuzumab- based adjuvant chemotherapy regimen: Should we abandon anthracyclines?', Journal of Clinical Oncology, vol. 30, no. 18, pp. 2179-2182. https://doi.org/10.1200/JCO.2012.42.0695
Burstein HJ, Piccart-Gebhart MJ, Perez EA, Hortobagyi GN, Wolmark N, Albain KS et al. Choosing the best trastuzumab- based adjuvant chemotherapy regimen: Should we abandon anthracyclines? Journal of Clinical Oncology. 2012 Jun 20;30(18):2179-2182. https://doi.org/10.1200/JCO.2012.42.0695
Burstein, Harold J. ; Piccart-Gebhart, Martine J. ; Perez, Edith A. ; Hortobagyi, Gabriel N. ; Wolmark, Norman ; Albain, Kathy S. ; Norton, Larry ; Winer, Eric P. ; Hudis, Clifford A. / Choosing the best trastuzumab- based adjuvant chemotherapy regimen : Should we abandon anthracyclines?. In: Journal of Clinical Oncology. 2012 ; Vol. 30, No. 18. pp. 2179-2182.
@article{cce5b24db121489fa1e7f9dfbfbd17c8,
title = "Choosing the best trastuzumab- based adjuvant chemotherapy regimen: Should we abandon anthracyclines?",
author = "Burstein, {Harold J.} and Piccart-Gebhart, {Martine J.} and Perez, {Edith A.} and Hortobagyi, {Gabriel N.} and Norman Wolmark and Albain, {Kathy S.} and Larry Norton and Winer, {Eric P.} and Hudis, {Clifford A.}",
year = "2012",
month = "6",
day = "20",
doi = "10.1200/JCO.2012.42.0695",
language = "English (US)",
volume = "30",
pages = "2179--2182",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "18",

}

TY - JOUR

T1 - Choosing the best trastuzumab- based adjuvant chemotherapy regimen

T2 - Should we abandon anthracyclines?

AU - Burstein, Harold J.

AU - Piccart-Gebhart, Martine J.

AU - Perez, Edith A.

AU - Hortobagyi, Gabriel N.

AU - Wolmark, Norman

AU - Albain, Kathy S.

AU - Norton, Larry

AU - Winer, Eric P.

AU - Hudis, Clifford A.

PY - 2012/6/20

Y1 - 2012/6/20

UR - http://www.scopus.com/inward/record.url?scp=84864018416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864018416&partnerID=8YFLogxK

U2 - 10.1200/JCO.2012.42.0695

DO - 10.1200/JCO.2012.42.0695

M3 - Article

VL - 30

SP - 2179

EP - 2182

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 18

ER -